Millennium Management
RNAM

Millennium Management’s Avidity Biosciences RNAM Stock Holding History

Millennium Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-258,000
Closed -$18.6M – 6286
2025
Q4 		$18.6M Buy
258,000
+250,100
+3,166% +$16.2M 0.01% 1646
2025
Q3 		$344K Sell
7,900
-7,100
-47% -$287K ﹤0.01% 5282
2025
Q2 		$426K Hold
15,000
– – ﹤0.01% 4996
2025
Q1 		$443K Buy
+15,000
New +$467K ﹤0.01% 4888

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Millennium Management's RNAM Position: Q1 2026 in Review

Millennium Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2,157,270 shares — an estimated $156M sold.

Millennium Management first reported a position in RNAM in Q2 2020 and held it in 19 quarters. The position peaked at $156M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Millennium Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 2,157,270 Avidity Biosciences shares in Q1 2026, an estimated $156M.
  • Millennium Management first reported a position in Avidity Biosciences in Q2 2020 and held it in 19 quarters.
  • Millennium Management's Avidity Biosciences position peaked at $156M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.